SB

Sumansingh Baldevsingh Rawat

Active Director Director DIN 10202214
DIN 10202214 First appointment Jun 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Sumansingh Baldevsingh Rawat

Data last updated:

Sumansingh Baldevsingh Rawat is a Director at Venamed Medicare Private Limited (since 2023). The company operates in Pharma.

DIN 10202214
Primary Designation Director
Industry Pharma
First Appointment 13 Jun 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Venamed Medicare Private Limited U46497MH2023PTC404840
Director13 Jun 20232023Active

Board colleagues of Sumansingh Baldevsingh Rawat

NameDINCompanyDesignation
Vikram Rana10250766Venamed Medicare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Venamed Medicare Private Limited
Premium access

Shareholding and investment profile for Sumansingh Baldevsingh Rawat

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sumansingh Baldevsingh Rawat

Sumansingh Baldevsingh Rawat currently holds 1 directorship: Venamed Medicare Private Limited (Director, since 13 Jun 2023).

Sumansingh Baldevsingh Rawat was first appointed on 13 Jun 2023 as Director at Venamed Medicare Private Limited.

The current boards of Sumansingh Baldevsingh Rawat's companies include Vikram Rana (Venamed Medicare Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available